DeepSeek R1 model debuted in January last year. After its launch, OpenAI CEO Sam Altman shared a post on X calling the AI model “impressive”, adding “.

The company claims the model demonstrates performance comparable to GPT-5.2-Thinking, Claude-Opus-4.5, and Gemini 3 Pro. Alibaba Cloud’s latest AI model, Qwen3-Max-Thinking, is staking a claim as one ...

For the first time since Tesla launched the Model 3 in China in 2019, another automaker has outsold it in the premium electric sedan segment. And it’s a smartphone company. Xiaomi delivered 258,164 ...

U.S. Border Patrol Cmdr. Greg Bovino recently took to the streets of Minneapolis, pulling the pin from a grenade and lobbing it into a crowd of protesters as plumes of vibrant green smoke filled the ...

The European Commission announced today that it has launched formal proceedings under the Digital Services Act to investigate whether X properly assessed risks before deploying its Grok artificial ...

SAN FRANCISCO and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (“MapLight”) (Nasdaq: MPLT) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast ...

“If at first you don’t succeed…” is half of a cliché knife designer Joe Caswell must be painfully familiar with, as the man seemingly spent most of last year living the “try, try again” part. After ...

The Supreme Court’s decision Tuesday blocking President Donald Trump from sending the National Guard into American cities is likely to raise a politically fraught debate about the president’s ...

Google is deploying a second AI model to monitor its Gemini-powered Chrome browsing agent after acknowledging the agent could be tricked into taking unauthorized actions through prompt injection ...

ChargePoint Holdings, Inc. (NYSE:CHPT) is one of the best EV charging stocks to buy now. ChargePoint Holdings, Inc. (NYSE:CHPT) has a Hold consensus from 11 analysts, with an average target of $12.88 ...

The CMS Innovation Center has debuted a new model to encourage the use of technology to treat chronic diseases, which could be a boon for health tech companies that have struggled with reimbursement.